Incidence and mortality of cutaneous lymphoma in North-Rhine Westphalia/Germany: recent trends and data of the population-based cancer registry of North Rhine Westphalia

2021 ◽  
Vol 156 ◽  
pp. S33
Author(s):  
Khodr Cheikh El Najjarine ◽  
Hiltraud Kajüter ◽  
Ina Wellmann ◽  
Andreas Stang ◽  
Chalid Assaf
Keyword(s):  
Cancer Registry ◽  
Population Based ◽  
Cutaneous Lymphoma ◽  
Incidence And Mortality ◽  
Recent Trends

National And Subnational Incidence of Bladder Cancer In Iran: Results of The Iranian National Population-Based Cancer Registry Over A 12-Year Period

2021 ◽  
Author(s):  
Mohammad Reza Nowroozi ◽  
Erfan Amini ◽  
Ehsan Mosa Farkhani ◽  
Ali Nowroozi ◽  
Mohsen Ayati ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Registry ◽  
Communicable Disease ◽  
Population Based ◽  
Incidence Rates ◽  
Population Based Study ◽  
Major Health Problem ◽  
Registry System ◽  
Incidence And Mortality ◽  
Non Communicable Disease

Abstract Background: Bladder cancer is one of the most common cancers worldwide and its incidence and mortality rates vary globally due to genetic variation, population age and exposure to risk factors. In the present study we aim to report national and subnational incidence of bladder cancer in Iran between 2003 and 2015.Methods: This population-based study investigate the age-standardized incidence rates (ASRs) of bladder cancer between 2003 and 2015 in Iran and its 32 provinces using last updated data from national cancer registry system of non-communicable disease center of Iran Ministry of Health, and Medical Education. Results: ASR of bladder cancer increased from 8.35 in 2003 to 13.57 in 2015 in men. ASR of bladder cancer also showed a mild increase in females, 2.12 in 2003 versus 2.86 in 2015.Conclusion: In conclusion, we observed an increasing trend of bladder cancer incidence in Iran, highlighting the disease as a potentially major health problem in the future. Therefore, it is necessary for health organizations to implement effective educational, preventive and therapeutic programs in the country to prevent further increase of disease burden.

scholarly journals Use of a Population-Based Cancer Registry to Calculate Twenty-Year Trends in Cancer Incidence and Mortality in Fukui Prefecture

2010 ◽  
Vol 20 (3) ◽  
pp. 244-252 ◽  
Author(s):  
Masakazu Hattori ◽  
Manabu Fujita ◽  
Yuri Ito ◽  
Akiko Ioka ◽  
Kota Katanoda ◽  
...  
Keyword(s):  
Cancer Registry ◽  
Cancer Incidence ◽  
Population Based ◽  
Incidence And Mortality

Primary cutaneous lymphoma: a population-based cancer registry descriptive study of 155 consecutive cases diagnosed between 1979 and 2016

2021 ◽  
pp. 1-6
Author(s):  
Laure Fréchet ◽  
Anne Sophie Woronoff ◽  
Aurélie Gérazime ◽  
Eve Puzenat ◽  
Anne Sophie Dupond ◽  
...  
Keyword(s):  
Cancer Registry ◽  
Descriptive Study ◽  
Population Based ◽  
Cutaneous Lymphoma ◽  
Primary Cutaneous Lymphoma

scholarly journals Presentation, Management, and Outcomes across the Rural-Urban Continuum for Hepatocellular Carcinoma

2020 ◽  
Author(s):  
Kali Zhou ◽  
Trevor A Pickering ◽  
Christina S Gainey ◽  
Myles Cockburn ◽  
Mariana C Stern ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Rural Communities ◽  
Urban Areas ◽  
Tumor Stage ◽  
The United States ◽  
Population Based ◽  
Urban Residents ◽  
Place Of Residence ◽  
Incidence And Mortality ◽  
Receive Treatment

Abstract Background Hepatocellular carcinoma is one of few cancers with rising incidence and mortality in the United States. Little is known about disease presentation and outcomes across the rural-urban continuum. Methods Using the population-based SEER registry, we identified adults with incident hepatocellular carcinoma between 2000–2016. Urban, suburban and rural residence at time of cancer diagnosis were categorized by the Census Bureau’s percent of the population living in non-urban areas. We examined association between place of residence and overall survival. Secondary outcomes were late tumor stage and receipt of therapy. Results Of 83,368 cases, 75.8%, 20.4%, and 3.8% lived in urban, suburban, and rural communities, respectively. Median survival was 7 months (IQR 2–24). All stage and stage-specific survival differed by place of residence, except for distant stage. In adjusted models, rural and suburban residents had a respective 1.09-fold (95% CI = 1.04–1.14, p < .001) and 1.08-fold (95% CI = 1.05–1.10, p < .001) increased hazard of overall mortality as compared to urban residents. Furthermore, rural and suburban residents had 18% (OR = 1.18, 95% CI 1.10–1.27, p < .001) and 5% (OR = 1.05, 95% CI = 1.02–1.09, p = .003) higher odds of diagnosis at late stage and were 12% (OR = 0.88, 95% CI = 0.80–0.94, p < .001) and 8% (OR = 0.92, 95% CI = 0.88–0.95, p < .001) less likely to receive treatment, respectively, compared to urban residents. Conclusions Residence in a suburban and rural community at time of diagnosis was independently associated with worse indicators across the cancer continuum for liver cancer. Further research is needed to elucidate the primary drivers of these rural-urban disparities.

scholarly journals Does access to care play a role in liver cancer survival? The ten-year (2006–2015) experience from a population-based cancer registry in Southern Italy

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Walter Mazzucco ◽  
Francesco Vitale ◽  
Sergio Mazzola ◽  
Rosalba Amodio ◽  
Maurizio Zarcone ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Access To Care ◽  
Cancer Registry ◽  
Health Care Services ◽  
Cancer Survival ◽  
Developed Countries ◽  
Population Based ◽  
Easy Access ◽  
Net Survival ◽  
Poor Access

Abstract Background Hepatocellular carcinoma (HCC) is the most frequent primary invasive cancer of the liver. During the last decade, the epidemiology of HCC has been continuously changing in developed countries, due to more effective primary prevention and to successful treatment of virus-related liver diseases. The study aims to examine survival by level of access to care in patients with HCC, for all patients combined and by age. Methods We included 2018 adult patients (15–99 years) diagnosed with a primary liver tumour, registered in the Palermo Province Cancer Registry during 2006–2015, and followed-up to 30 October 2019. We obtained a proxy measure of access to care by linking each record to the Hospital Discharge Records and the Ambulatory Discharge Records. We estimated net survival up to 5 years after diagnosis by access to care (“easy access to care” versus “poor access to care”), using the Pohar-Perme estimator. Estimates were age-standardised using International Cancer Survival Standard (ICSS) weights. We also examined survival by access to care and age (15–64, 65–74 and ≥ 75 years). Results Among the 2018 patients, 62.4% were morphologically verified and 37.6% clinically diagnosed. Morphologically verified tumours were more frequent in patients aged 65–74 years (41.6%), while tumours diagnosed clinically were more frequent in patients aged 75 years or over (50.2%). During 2006–2015, age-standardised net survival was higher among HCC patients with “easy access to care” than in those with “poor access to care” (68% vs. 48% at 1 year, 29% vs. 11% at 5 years; p < 0.0001). Net survival up to 5 years was higher for patients with “easy access to care” in each age group (p < 0.0001). Moreover, survival increased slightly for patients with easier access to care, while it remained relatively stable for patients with poor access to care. Conclusions During 2006–2015, 5-year survival was higher for HCC patients with easier access to care, probably reflecting progressive improvement in the effectiveness of health care services offered to these patients. Our linkage algorithm could provide valuable evidence to support healthcare decision-making in the context of the evolving epidemiology of hepatocellular carcinoma.

Sign in / Sign up

Export Citation Format

Share Document